ConductScience.org, home

Paper41300969

Molecular Prognosticators Guiding Fertility-Sparing Surgery in Early-Stage Endometrial Cancer: A Comprehensive Review.

Shaikh S and 10 others. Cancers (Basel), 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Molecular Prognosticators Guiding Fertility-Sparing Surgery in Early-Stage Endometrial Cancer: A Comprehensive Review. Papers, record 41300969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300969

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular Prognosticators Guiding Fertility-Sparing Surgery in Early-Stage Endometrial Cancer: A Comprehensive Review.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-11-30
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shaikh SSaniyahhttps://orcid.org/0009-0008-3715-582X
2Haque SSalsabil
3Khalifey HTHafsah Tajammulhttps://orcid.org/0009-0001-5984-705X
4Samour HAHalla Anashttps://orcid.org/0009-0008-4731-1523
5Deed AAyeshahttps://orcid.org/0009-0000-3272-786X
6Mahereen RRutabahttps://orcid.org/0009-0005-0249-5929
7Nabiha NNoorhttps://orcid.org/0009-0006-3917-3875
8Shaikh SSafwaanhttps://orcid.org/0009-0009-2615-508X
9Samhan LMLara Mhttps://orcid.org/0000-0002-6595-859X
10Khan MIMohammed Imran
11Yaqinuddin AAhmedhttps://orcid.org/0000-0001-7536-910X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References99

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124388202Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis.Fertil Steril2014https://conductscience.org/library/papers/24388202PubMed
239235934Understanding risk factors for endometrial cancer in young women.J Natl Cancer Inst2025https://conductscience.org/library/papers/39235934PubMed
333039397Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.Am J Obstet Gynecol2021https://conductscience.org/library/papers/33039397PubMed
423636398Integrated genomic characterization of endometrial carcinoma.Nature2013https://conductscience.org/library/papers/23636398PubMed
534607827Correction: Improving response to progestin treatment of low-grade endometrial cancer.Int J Gynecol Cancer2021https://conductscience.org/library/papers/34607827PubMed
635274725Perspectives of Young Women With Gynecologic Cancers on Fertility and Fertility Preservation: A Systematic Review.Oncologist2022https://conductscience.org/library/papers/35274725PubMed
735269674Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions.Int J Mol Sci2022https://conductscience.org/library/papers/35269674PubMed
831056702
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Ann Oncol2019https://conductscience.org/library/papers/31056702PubMed
931846532Incorporation of molecular characteristics into endometrial cancer management.Histopathology2020https://conductscience.org/library/papers/31846532PubMed
1036358604Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes.Cancers (Basel)2022https://conductscience.org/library/papers/36358604PubMed
1136690721Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.Br J Cancer2023https://conductscience.org/library/papers/36690721PubMed
1233251877Dostarlimab in the treatment of recurrent or primary advanced endometrial cancer.Future Oncol2021https://conductscience.org/library/papers/33251877PubMed
1333205638Fertility-sparing management for endometrial cancer: review of the literature.Minerva Med2021https://conductscience.org/library/papers/33205638PubMed
1438540726Reproductive and Oncologic Outcomes in Young Women with Stage IA and Grade 2 Endometrial Carcinoma Undergoing Fertility-Sparing Treatment: A Systematic Review.Biomolecules2024https://conductscience.org/library/papers/38540726PubMed
1528352680Endometrial cancer and microsatellite instability status.Open Med (Wars)2015https://conductscience.org/library/papers/28352680PubMed
1634830129Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification.Int J Mol Sci2021https://conductscience.org/library/papers/34830129PubMed
1723744837Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy.Cancer Res2013https://conductscience.org/library/papers/23744837PubMed
1824844595POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.Gynecol Oncol2014https://conductscience.org/library/papers/24844595PubMed
1936756380ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma.Hum Reprod Open2023https://conductscience.org/library/papers/36756380PubMed
2035269800Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing Treatment (FST) Decision Making in Early Stage Endometrial Cancer (ES-EC): A Systematic Review.Int J Mol Sci2022https://conductscience.org/library/papers/35269800PubMed

See all 99 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42940054Association of VCP/p97 Expression with Clinicopathological Features and Overall Survival in Endometrioid Endometrial Carcinoma.Biomedicines2026https://conductscience.org/library/papers/42940054PubMed
42755554Molecular classification of endometrial cancer in fertility-sparing-treatment: toward a personalized clinical approach.Front Oncol2026https://conductscience.org/library/papers/42755554PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41300969

GET https://conductscience.org/api/papers/v1/41300969/references?page=2